620
Participants
Start Date
June 30, 2002
Primary Completion Date
July 31, 2004
Study Completion Date
December 31, 2004
bortezomib
Institut Jules Bordet, Unite Sterile, Brussels
CHU Erasme / ULB University, Hematology 7th Floor, Brussels
Dept. of Clinical Hematology, Academic Medical Center, Amsterdam
Wilhelminenspital Wien, Abt. Fur Med. und Medizinische Onkologie, Vienna
ACZA, Campus Stuivenberg, Antwerp
UZ Gasthuisberg, Department of Hematology, Leuven
Department of Hematology, Erasmus MC, 1a, Daniel Den Hoed, Rotterdam
Cliniques Universitaires U.C.L de Mont Godinne, Hopital de Jour, Yvoir
C.H. Notre Dame-Reine Fabiola, Charleroi
AZ St. Jan, Dept. of Haematology, Rugge
St. Vincent's Comprehensive Cancer Center, Research Department, New York
NY Presbyterian Hospital, New York
Universitatsklinikum Charite, Abt. Fuer Haematologie/Onkologie, Berlin
Azienda Ospedaliera, S. Giovanni Battista, Torino
Long Island Jewish Medical Center, Division of Hematology/Oncology, New Hyde Park
Department of Haematology, Huddinge University Hospital M54, Stockholm
Roswell Park Cancer Institute, Buffalo
Rochester General Hospital, Lipson Cancer Blood Center, Rochester
University of Rochester Medical Center, James P. Wilmot Cancer Center, Rochester
Western Pennsylvania Hospital, Dept. of Human Oncology, Pittsburgh
Karolinska Hospital, Dept. of Hematology, Stockholm
University of Pennsylvania Cancer Center, Philadelphia
Lombardi Cancer Center, Georgetown University Medical Center, Washington D.C.
Med Star Institute, Washington Cancer Center, Washington D.C.
Medical University Clinic (Oncology/Haematology), Hamburg
Dipartmento Clinico esperimentale Di Oncologia et Ematolgia, Bergamo
Carolinas Hematology-Oncology Associates, Charlotte
Trident Palmetto Hematology/Oncology, Charleston
Emory University, Atlanta
Hopital Purpan, Pavillon Dieulafoy, Service d'Hematologie Clinique, Toulouse
RAMBAM Medical Center, Department of Hematology and Bone, Haifa
Hematology/Oncology Associates, PA, Jacksonville
University of Miami, Miami
H. Lee Moffitt Cancer Center, University of S. Florida, Tampa
University Hospital of Salamanca, Salamanca
Instituto di Ematologia e Oncologia Medica, Lorenzo e Ariosto Seragnoli, Bologna
Cleveland Clinic Foundation, Cleveland
Uniklinikum Muenster, Münster
Medizinische Klinik und Poliklinik 1, Bonn
Medical College of Wisconsin, Milwaukee
Hopital de Brabois, Service Hematologie et Medecine Interne, Vandœuvre-lès-Nancy
Johannes Gutenberg-Universitat Mainz, III. Med Klinik und Poliknik, Mainz
VA Medical Center, Sections of Hematology/Oncology, Minneapolis
Mayo Clinic, Rochester
Hospital Claude Huriez, Service des Maladies du Sang, Lille
St. Marien Hospital, Klinik fur Hamatologie und Onkologie, Hamm
Loyola University Medical Center: Cardinal Bernardin Cancer Center, Maywood
Northwestern University Medical School, Chicago
Washington University School of Medicine, St Louis
Universitatsklinikum Heidelberg, Abt. Fur Haematologie und Onkologie, Heidelberg
Centre Hospitalier Lyon Sud, Pierre-Bénite
LSU HC, Shreveport
Eberhard-Karls Universitat, Medizinische Klinik, Tübingen
Hopital Hotel Dieu, Service d'hematologie et oncologie medicale, Paris
Hopital Saint-Louis, Direction Financiere, Paris
Hopital Cochin, Service de Hematologie, Paris
Texas Oncology at Medical City Dallas Hospital, Dallas
Baylor Institute for Immunology Research, Dallas
MD Anderson Cancer Center, Houston
Freiburg University Medical Center, Dept. of Hemayology/Oncology, Freiburg im Breisgau
City of Hope, Duarte
University of Erlangen-Nurenberg, Division of Hematology/Oncology, Erlangen
Hadassah University Hospital, Jerusalem
Hopital Antoine Beclere, Hopital de Jour de Medecine Interne, Clamart
Scripps Clinic, La Jolla
Loma Linda University Medical Center, Loma Linda
Kaiser Permanente Oncology Clinical Trials, Vallejo
Alta Bates Comprehensive Cancer Center, Berkeley
Institut Gustave-Roussy, Service d'Hematologie, Villejuif
Fred Hutchinson Cancer Center, Seattle
Tufts New England Medical Center, Boston
Dana-Farber Cancer Center, Boston
Beth Israel Deaconess Medical Center, Kirstein Room 135, Boston
Department of Internal Medicine, Univ. of Michigan Comp. Cancer Center, Ann Arbor
Hackensack University Medical Center, David Jurist Research Building, Hackensack
Division of Hematology/Stem Cell Transplant, Nashville
Cross Cancer Institute, Edmonton
London Health Sciences Center, London
Toronto General Research Institute, Princess Margaret Hospital, Toronto
Royal Victoria Hospital, Montreal
Nantes Hotel Dieu Hospital, Nantes
Universitatsklinikum Carl Gustav Carus, Dresden
University of Essen Medical School, Dept. of Internal Medicine, Hufelandstr
Belfast City Hospital, Belfast
Dipartimento di Biotecnologie Cellulari ed Ematologia, Roma
Dept. Hematology, University Medical Centre, Utrecht
Hospital Clinico Universitario de Barcelona, Haematology Department, Barcelona
Adult Leukaemia Unit, Christie Hospital, Withington
Department of Haematology, Queen Elizabeth Hospital, Birmingham
Leeds General Infirmary, Leeds
Department of Haematology, St. Bartholomew's Hospital, London
Department of Haematology, ICSM, Hammersmith Hospital, London
Royal Marsden Hospital, Leukaemia and Myeloma Units, Sutton
Lead Sponsor
Millennium Pharmaceuticals, Inc.
INDUSTRY